Drug-Induced Acneform Eruptions: Definitions and Causes

Article Type
Changed
Thu, 01/10/2019 - 12:39
Display Headline
Drug-Induced Acneform Eruptions: Definitions and Causes

Article PDF
Author and Disclosure Information

Momin S, Peterson A, Del Rosso JQ

Issue
Cutis - 83(1)
Publications
Page Number
28-37
Legacy Keywords
acneform, drugs, acne vulgaris, lymphocytic, neutrophilic, hypercornification, inflammation, corticosteroids, monomorphic, papules, pustules, erythema, flare-ups, percutaneous, stratum corneum, facial skin, sebaceous, follicles, triglycerides, comedogenesis, epidermal growth factor receptors, epidermal growth factor receptor inhibitors, pathogenesis, EGF-RI, EGF-R, skin lesions, cetuximab, trastazumab, panitumumbab, monoclonal, serrheic, retroauricular, perifolliculitis, acantholysis, comedone, cell-cycle, Propionibacterium acnes, hyperkeratosis, granulocyte, anti-tumor necrosis, sirolimus, cyclosporine, imatinib, tyrosine kinase, myelogenous keukemia, granulocyte-macrophage, mucous membrane, testosterone, hypercornification, cyclosporine methandrostenolone, ethylestrenol, stanozolol, fluoxymesterone, oxymetholone, oxandrolone, nandrolone phenylpropionate, nandrolone deconoate, testosterone enanthate, testosterone cypionate, testosterone propionate, danazol, levonorestrel, valproate, aMomin S, Peterson A, Del Rosso JQ, acneform, drugs, acne vulgaris, lymphocytic, neutrophilic, hypercornification, inflammation, corticosteroids, monomorphic, papules, pustules, erythema, flare-ups, percutaneous, stratum corneum, facial skin, sebaceous, follicles, triglycerides, comedogenesis, epidermal growth factor receptors, epidermal growth factor receptor inhibitors, pathogenesis, EGF-RI, EGF-R, skin lesions, cetuximab, trastazumab, panitumumbab, monoclonal, serrheic, retroauricular, perifolliculitis, acantholysis, comedone, cell-cycle, Propionibacterium acnes, hyperkeratosis, granulocyte, anti-tumor necrosis, sirolimus, cyclosporine, imatinib, tyrosine kinase, myelogenous keukemia, granulocyte-macrophage, mucous membrane, testosterone, hypercornification, cyclosporine methandrostenolone, ethylestrenol, stanozolol, fluoxymesterone, oxymetholone, oxandrolone, nandrolone phenylpropionate, nandrolone deconoate, testosterone enanthate, testosterone cypionate, testosterone propionate, danazol, levonorestrel, valproate, amineptine, polycystic ovarian syndome, hirsutism, acne, alopecia, bipolar disorder, dactinomycin, hydantoin, lithium carbonate, dantrolene, isotretinoin, antituberculosis drugs, quinidine, tacrolimus, beta-blocker, dapsone, azathioprine, lamotrigine, gold, psoralen-UVA, PUVA, vitamin B6, vitamin B12, tetracycline, tetraethylthiuram disulfide, halogens, white petrolatum, sunscreen, cow udder ointment
Sections
Author and Disclosure Information

Momin S, Peterson A, Del Rosso JQ

Author and Disclosure Information

Momin S, Peterson A, Del Rosso JQ

Article PDF
Article PDF

Issue
Cutis - 83(1)
Issue
Cutis - 83(1)
Page Number
28-37
Page Number
28-37
Publications
Publications
Article Type
Display Headline
Drug-Induced Acneform Eruptions: Definitions and Causes
Display Headline
Drug-Induced Acneform Eruptions: Definitions and Causes
Legacy Keywords
acneform, drugs, acne vulgaris, lymphocytic, neutrophilic, hypercornification, inflammation, corticosteroids, monomorphic, papules, pustules, erythema, flare-ups, percutaneous, stratum corneum, facial skin, sebaceous, follicles, triglycerides, comedogenesis, epidermal growth factor receptors, epidermal growth factor receptor inhibitors, pathogenesis, EGF-RI, EGF-R, skin lesions, cetuximab, trastazumab, panitumumbab, monoclonal, serrheic, retroauricular, perifolliculitis, acantholysis, comedone, cell-cycle, Propionibacterium acnes, hyperkeratosis, granulocyte, anti-tumor necrosis, sirolimus, cyclosporine, imatinib, tyrosine kinase, myelogenous keukemia, granulocyte-macrophage, mucous membrane, testosterone, hypercornification, cyclosporine methandrostenolone, ethylestrenol, stanozolol, fluoxymesterone, oxymetholone, oxandrolone, nandrolone phenylpropionate, nandrolone deconoate, testosterone enanthate, testosterone cypionate, testosterone propionate, danazol, levonorestrel, valproate, aMomin S, Peterson A, Del Rosso JQ, acneform, drugs, acne vulgaris, lymphocytic, neutrophilic, hypercornification, inflammation, corticosteroids, monomorphic, papules, pustules, erythema, flare-ups, percutaneous, stratum corneum, facial skin, sebaceous, follicles, triglycerides, comedogenesis, epidermal growth factor receptors, epidermal growth factor receptor inhibitors, pathogenesis, EGF-RI, EGF-R, skin lesions, cetuximab, trastazumab, panitumumbab, monoclonal, serrheic, retroauricular, perifolliculitis, acantholysis, comedone, cell-cycle, Propionibacterium acnes, hyperkeratosis, granulocyte, anti-tumor necrosis, sirolimus, cyclosporine, imatinib, tyrosine kinase, myelogenous keukemia, granulocyte-macrophage, mucous membrane, testosterone, hypercornification, cyclosporine methandrostenolone, ethylestrenol, stanozolol, fluoxymesterone, oxymetholone, oxandrolone, nandrolone phenylpropionate, nandrolone deconoate, testosterone enanthate, testosterone cypionate, testosterone propionate, danazol, levonorestrel, valproate, amineptine, polycystic ovarian syndome, hirsutism, acne, alopecia, bipolar disorder, dactinomycin, hydantoin, lithium carbonate, dantrolene, isotretinoin, antituberculosis drugs, quinidine, tacrolimus, beta-blocker, dapsone, azathioprine, lamotrigine, gold, psoralen-UVA, PUVA, vitamin B6, vitamin B12, tetracycline, tetraethylthiuram disulfide, halogens, white petrolatum, sunscreen, cow udder ointment
Legacy Keywords
acneform, drugs, acne vulgaris, lymphocytic, neutrophilic, hypercornification, inflammation, corticosteroids, monomorphic, papules, pustules, erythema, flare-ups, percutaneous, stratum corneum, facial skin, sebaceous, follicles, triglycerides, comedogenesis, epidermal growth factor receptors, epidermal growth factor receptor inhibitors, pathogenesis, EGF-RI, EGF-R, skin lesions, cetuximab, trastazumab, panitumumbab, monoclonal, serrheic, retroauricular, perifolliculitis, acantholysis, comedone, cell-cycle, Propionibacterium acnes, hyperkeratosis, granulocyte, anti-tumor necrosis, sirolimus, cyclosporine, imatinib, tyrosine kinase, myelogenous keukemia, granulocyte-macrophage, mucous membrane, testosterone, hypercornification, cyclosporine methandrostenolone, ethylestrenol, stanozolol, fluoxymesterone, oxymetholone, oxandrolone, nandrolone phenylpropionate, nandrolone deconoate, testosterone enanthate, testosterone cypionate, testosterone propionate, danazol, levonorestrel, valproate, aMomin S, Peterson A, Del Rosso JQ, acneform, drugs, acne vulgaris, lymphocytic, neutrophilic, hypercornification, inflammation, corticosteroids, monomorphic, papules, pustules, erythema, flare-ups, percutaneous, stratum corneum, facial skin, sebaceous, follicles, triglycerides, comedogenesis, epidermal growth factor receptors, epidermal growth factor receptor inhibitors, pathogenesis, EGF-RI, EGF-R, skin lesions, cetuximab, trastazumab, panitumumbab, monoclonal, serrheic, retroauricular, perifolliculitis, acantholysis, comedone, cell-cycle, Propionibacterium acnes, hyperkeratosis, granulocyte, anti-tumor necrosis, sirolimus, cyclosporine, imatinib, tyrosine kinase, myelogenous keukemia, granulocyte-macrophage, mucous membrane, testosterone, hypercornification, cyclosporine methandrostenolone, ethylestrenol, stanozolol, fluoxymesterone, oxymetholone, oxandrolone, nandrolone phenylpropionate, nandrolone deconoate, testosterone enanthate, testosterone cypionate, testosterone propionate, danazol, levonorestrel, valproate, amineptine, polycystic ovarian syndome, hirsutism, acne, alopecia, bipolar disorder, dactinomycin, hydantoin, lithium carbonate, dantrolene, isotretinoin, antituberculosis drugs, quinidine, tacrolimus, beta-blocker, dapsone, azathioprine, lamotrigine, gold, psoralen-UVA, PUVA, vitamin B6, vitamin B12, tetracycline, tetraethylthiuram disulfide, halogens, white petrolatum, sunscreen, cow udder ointment
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

Clindamycin Phosphate 1.2%–Tretinoin 0.025% Gel: Vehicle Characteristics, Stability, and Tolerability

Article Type
Changed
Thu, 01/10/2019 - 12:14
Display Headline
Clindamycin Phosphate 1.2%–Tretinoin 0.025% Gel: Vehicle Characteristics, Stability, and Tolerability

Article PDF
Author and Disclosure Information

Del Rosso JQ, Jitpraphai W, Bhambri S, Momin S

Issue
Cutis - 81(5)
Publications
Topics
Page Number
405-408
Sections
Author and Disclosure Information

Del Rosso JQ, Jitpraphai W, Bhambri S, Momin S

Author and Disclosure Information

Del Rosso JQ, Jitpraphai W, Bhambri S, Momin S

Article PDF
Article PDF

Issue
Cutis - 81(5)
Issue
Cutis - 81(5)
Page Number
405-408
Page Number
405-408
Publications
Publications
Topics
Article Type
Display Headline
Clindamycin Phosphate 1.2%–Tretinoin 0.025% Gel: Vehicle Characteristics, Stability, and Tolerability
Display Headline
Clindamycin Phosphate 1.2%–Tretinoin 0.025% Gel: Vehicle Characteristics, Stability, and Tolerability
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media